Marc Beer aims to provide better health for women across the country. With his goal in mind, he established a startup called Renovia Inc., and through this company, he introduced the Leva Pelvic Digital Health System. Formerly a chief executive of a different pharmaceutical company, Marc Beer has the experience to run a business successfully. One of the recent highlights of his career serving Renovia Inc. would be the closing of a $32 million funding from investors who wanted to help out the company. In addition to this, Marc Beer has also secured a $10 million venture debt. The $42 million funding that he secured will be used to improve the products and services offered by the company, and he also highlighted the possibility of creating new treatment methods that would benefit the public.
Renovia Inc. is based in Boston, Massachusetts, and the company has been developing therapeutic and diagnostic products that would help women who are suffering from different conditions. Marc Beer focused the company’s research on pelvic floor disorder, which is believed to affect 250 million women, with the majority of them experiencing urinary incontinence. Pelvic floor disorder is triggered normally by childbirth, but there are other causes on why the disorder develops. Renovia Inc.’s Leva Pelvic Digital Health System was submitted to the FDA early in 2018, and they received the approval from the government agency by April.
Marc Beer felt thankful to everyone who invested with the company, and he said that the fund given to them will be put into good use. The Longwood Fund, which is an investment firm that focuses heavily on medical companies, provided the largest amount of investment to Renovia Inc. They said that they are willing to invest in a company that has a clear goal, and their interest was captured by Marc Beer’s plans of creating a new generation Leva Pelvic Digital Health System. They said that investing in women’s health is a great idea, and they are seeing optimistic growth with the company in the coming years. Marc Beer said that The Longwood Fund is supportive of their plans on creating new products and services that provide treatment for a variety of conditions affecting the females, and he also revealed that their research department is already working to find out new treatments for many diseases. Learn more: https://ideamensch.com/marc-beer/
The career of Marc Beer has seen a lot of improvement after he holds the position to become the CEO of the startup company that he founded. He is now regarded as one of the top business people in the country, thanks to the success of the products that his company introduced. He also gained recognition from different organizations because of his goal to help women who are suffering from different disorders
Marc Beer has taken the fight against pelvic floor disorders to the next level by securing financing for his women health startup, Renovia, Inc. He successfully raised $42 million in venture debt and Series B round. The women health startup now is set to move forward with development of four main products including the new generation of the Leva device. Renovia is a pharmaceutical company that is committed to improve the lives of women living with pelvic floor disorders around the world.
According to a research, urinary incontinence affects over 250 million women across the world. Mr. Marc Beer’s company has been dedicated to developing diagnostic and therapeutic products to treat the disorders. Since inception, the company has made incredible progress with some of its products receiving FDA approval. The company’s Leva device received FDA approval in April this year.
He raised $32 million in Series B round and $10 million in venture debt. Big players in the healthcare industry participated in Series B round conducted by the New York-based Perceptive Advisors and Missouri-based Ascension Ventures. The funding will boost the company’s efforts significantly with the development of the four pelvic floor disorder treatment products.
Marc Beer was excited by the move of the players in the industry to support him in his fight against the disorders. He has so far received unwavering support from the leading investors in the healthcare industry. He said in a statement that the investors shares his vision of improving the lives of women across the world who are suffering from pelvic floor disorders. Using cutting edge technology and solutions, he aims to make valuable data accessible to customers. The data generated will inform better pelvic floor disorder treatment options, build on the existing knowledge and eventually, promote the understanding of the disorders. The efforts are directed towards reduce healthcare costs in the long-run. Learn more: https://renoviainc.com/leadership/
The renowned healthcare entrepreneur has led a noble career in the industry. He was a strategic consultant in OvaScience, a pharmaceutical company which later merged with Millendo Therapeutics. Marc Beer is the CEO as well as Co-founder of Renovia, a Boston-based medtech company. He has over 25 years of experience in the industry with a specialty on development and commercialization in biotechnology, pharmaceutical, diagnostic as well as device industries. He a BS graduate from Miami University, OHIO.
He founded ViaCell and established it over time to have over 300 employees and later, go public. The company was acquired in 2007 by PerkinElmer. He is also a member of the board of directors of Erytech Pharmaceuticals. Marc Beer is also the Founding Chairman of committee of Good Start Genetics’ board of directors. He also holds prestigious positions in Minerva Neurosciences. He is also a member of Miami University Business Advisory Council. He served in other prestigious positions.